Genetics of HIV-1 infection: Chemokine receptor CCR5 polymorphism and its consequences

Human Molecular Genetics

Volumn 8, Issue 10, 1999, Pages 1939-1945

  Carrington, Mary ^a   Dean, Michael ^b   Martin, Maureen P ^a   O'Brien, Stephen J ^b  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR5;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CELL SURFACE; CHROMOSOME 3; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLECULAR GENETICS; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; VIRUS ENVELOPE;

HIV INFECTIONS; HIV-1; HUMANS; LINKAGE DISEQUILIBRIUM; MUTATION; OPEN READING FRAMES; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RECEPTORS, CCR5; VARIATION (GENETICS);

EID: 0032837669     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/8.10.1939     Document Type: Review

References (60)

1. Murphy, P.M. (1996) Chemokine receptors: structure, function and role in microbial pathogenesis. Cytokine Growth Factor Rev., 7, 47-64.
2. Premack, B.A. and Schall, T.J. (1996) Chemokine receptors: gateways to inflammation and infection. Nature Med., 1, 1174-1178.
3. Alkhatib, G., Combadiere, C., Broder, C.C., Feng, Y., Kennedy, P.E., Murphy, P.M. and Berger, E.A. (1996) CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science, 272, 1955-1958.
4. Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P.D., Wu, L., Mackay, C.R., LaRosa, G., Newman, W., Gerard, N., Gerard, C. and Sodroski, J. (1996) The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell, 85, 1135-1148.
5. Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Di Marzio, P., Marmon, S., Sutton, R.E., Hill, C.M., Davis, C.B., Peiper, S.C., Schall, T.J., Littman, D.R. and Landau, N.R. (1996) Identification of a major co-receptor for primary isolates of HIV-1. Nature, 381, 661-666.
6. Doranz, B.J., Rucker, J., Yi, Y., Smyth, R.J., Samson, M., Peiper, S.C., Parmentier, M., Collman, R.G. and Doms, R.W. (1996) A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell, 85, 1149-1158.
7. Dragic, T., Litwin, V., Allaway, G.P., Martin, S.R., Huang, Y., Nagashima, K.A., Cayanan, C., Maddon, P.J., Koup, R.A., Moore, J.P. and Paxton, W.A. (1996) HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature, 381, 667-673.
8. Moore, J.P., Trkola, A. and Dragic, T. (1997) Co-receptors for HIV-1 entry. Curr. Opin. Immunol., 9, 551-562.
9. Berger, E.A. (1997) HIV entry and tropism: the chemokine receptor connection. AIDS, 11, S3-S16.
10. Berger, E.A., Doms, R.A., Fenyo, E.M., Korber, B.T.M., Littman, D.R., Moore, J.P., Sattentau, Q.J., Schuitemaker, H., Sodroski, J. and Weiss, R.A. (1998) A new classification for HIV-1. Nature, 391, 240.
11. Zhu, T., Mo, H., Wang, N., Nam, D.S., Cao, Y., Koup, R.A. and Ho, D.D. (1993) Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science, 261, 1179-1181.
12. Richman, D.D. and Bozzette, S.A. (1996) The impact of the synctium-inducing phenotype of human immunodeficiency virus on disease progression. J. Infect. Dis., 169, 968-974.
13. Samson, M., Soularue, P., Vassart, G. and Parmentier, M. (1996) The genes encoding the human CC-chemokine receptors CC-CKR1 to CC-CKR5 (CMKBR1-CMKBR5) are clustered in the p21.3-p.24 regions of chromosome 3. Genomics, 36, 522-526.
14. Dean, M., Carrington, M., Winkler, C., Huttley, G.A., Smith, M.W., Allikmets, R., Goedert, J.J., Buchbinder, S.P., Vittinghoff, E., Gomperts, E., Donfield, S., Vlahov, D., Kaslow, R., Saah, A., Rinaldo, C., Detels, R., Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study and O'Brien, S.J (1996) Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science, 273, 1856-1862.
15. Liu, R., Paxton, W.A., Choe, S., Ceradini, D., Martin, S.R., Horuk, R., MacDonald, M.E., Stuhlmann, H., Koup, R.A. and Landau, N.R. (1996) Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell, 86, 367-377.
16. Samson, M, Libert, F., Doranz, B.J., Rucker, J., Liesnard, C., Farber, C.M., Saragosti, S., Lapoumeroulie, C., Cognaux, J., Forceille, C., Muyldermans, G., Verhofstede, C., Burtonboy, G., Georges, M., Imai, T., Rana, S., Yi, Y., Smyth, R.J., Collman, R.G., Doms, R.W., Vassart, G. and Parmentier, M. (1996) Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature, 382, 722-725.
17. Biti, R., French, R., Young, J., Bennets, B., Stewart, G. and Liang, T. (1997) HIV infection in an individual homozygous for the CCR5 deletion allele. Nature Med., 3, 252-253.
18. O'Brien, T.R., Winkler, C., Dean, M., Nelson, J.A.E., Carrington, M., Michael, N.L., and White, G.C.II (1997) HIV-1 infection in a man homozygous for CCR5Δ 32. Lancet, 349, 1219.
19. Theodorou, I., Meyer, L., Magierowska, M., Katlama, C., and Rouzioux, C. (1997) HIV-1 infection in an individual homozygous for CCR5Δ32. Lancet, 349, 1219-1220.
20. Zimmerman, P.A., Bukckler-White, A., Alkhatib, G., Spalding, T., Kubofxik, J., Combadiere, C., Weissman, D., Cohen, O., Rubbert, A., Lam, G., Vaccarezza, M., Kennedy, P.E., Kumanaswami, V., Giorgi, J.V., Detels, R., Hunter, J., Chopek, M., Berger, E.A., Fauci, A.S., Nutman, T.B. and Murphy, P.M. (1997) Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol. Med., 3, 23-26.
21. de Roda Husman, A.-M., Koot, M., Comelissen, M., Keet, I.P.M., Brouwer, M., Broersen, S.M., Bakker, M., Roos, M.T.L., Prins, M., de Wolf, F., Coutinho, R.A., Miedema, F., Goudsmit, J. and Schuitemaker, H. (1997) Association between CCR5 genotype and the clinical course of HIV-1 infection. Ann. Intern. Med., 127, 882-890.
22. Michael, N.L., Chang, G., Louie, L.G., Mascola, J.R., Dondero, D., Birx, D.L. and Sheppard, H.W. (1997) The role of viral phenotype and CCR5 gene defects in HIV-1 transmission and disease progression. Nature Med., 3, 338-340.
23. Wu, L., Paxton, W.A., Kassam, N., Ruffing, N., Rottman, J.B., Sullivan, N., Choe, H., Dosroski, J., Newman, W., Koup, R.A. and Mackay, C.R. (1997) CCR5 levels and expression pattern correlate with infectabilily by macrophage-tropic HIV-1 in vitro. J. Exp. Med., 185, 1681-1691.
24. Benkirane, M., Jin, D.Y., Chun, R.F., Koup, R.A. and Jeang, K.T. (1997) Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by CCR5Δ32. J. Biol. Chem., 272, 30603-30606.
25. Rabkin, C.S., Yang, Q., Goedert, J.J., Nguyen, G., Mitsuya, H. and Sei, S. (1999) Chemokine and chemokine receptor gene variants and risk of non-Hodgkin's lymphoma in human immunodeficiency virus-1-infected individuals. Blood, 93, 1838-1842.
26. Dean, M., Jacobson, L.P., McFarlane, G., Margolick, J.B., Jenkins, F.J., Howard, O.M.Z., Dong, H.-F., Goedert, J.J., Buchbinder, S., Gomperts, E., Vlahov, D., Oppenheim, J.J., O'Brien, S.J. and Carrington, M. (1999) Reduced risk of AIDS lymphoma in individuals heterozygous for the CCR5-Δ32 mutation. Cancer Res., 59, 3561-3564.
27. Stephens, J.C., Reich, D.E., Goldstein, D.B., Shin, H.D., Smith, M.W., Carrington, M., Winkler, C., Huttley, G.A., Allikmets, R., Schriml, L., Gerrard, B., Malasky, M., Ramos, M.D., Morlot, S., Tzetis, M., Oeddoux, C., di Giovine, F.S., Nasioulas, G., Chandler, D., Aseev, M., Hanson, M., Kalaydjieva, L., Glavac, D., Gasparini, P., Kanavakis, E., Claustres, M., Kambouris, M., Ostrer, H., Duff, G., Baranov, V., Sibul, H., Goldman, D., Martin, N., Duffy, D., Schmidtke, J., Estivill, X., O'Brien, S.J. and Dean, M. (1998) Dating the origin of the CCR5-Δ32 AIDS-resistance allele by the coalesence of haplotypes. Am. J. Hum. Genet., 62, 1507-1515.
28. Libert, F., Cochaus, P., Beckman, G., Samson, M., Aksenova, M., Cao, A., Czeizel, A. et al. (1998). The ΔCCR5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in northeastern Europe. Hum. Mol. Genet., 7, 399-406.
29. Martinson, J.J., Chapman, N.H., Rees, D.C., Liu, Y.T. and Clegg, J.B. (1997) Global distribution of the CCR5 gene 32-basepair deletion. Nature Genet., 16, 100-103.
30. Ansari-Lari, M.A., Liu, X.M., Metzker, M.L., Rut, A.R. and Gibbs, R.A. (1997) The extent of genetic variation in the CCR5 gene. Nature Genet., 16, 221-222.
31. Carrington, M., Kissner, T., Gerrard, B., Ivanov, S., O'Brien, S.J. and Dean, M. (1997) Novel alleles of the chemokine receptor gene CCR5. Am. J. Hum. Genet., 61, 1261-1267.
32. Li, W.H. (1997) Molecular Evolution. Sinauer Association, Sunderland, MA.
33. Quillent, C., Oberlin, E., Braun, J., Rousset, D., Gonzalez-Canali, G., Metais, P., Montagnier, L. and Virelizer, J.L. (1998) HIV-1 resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene. Lancet, 351, 14-18.
34. Howard, O.M.Z., Shirakawa, A.-K., Turpin, J.A., Maynard, A., Tobin, G.J., Carrington, M., Oppenheim, J.J. and Dean, M. (1999) Naturally occurring CCR5 extracellular and transmembrane domain variants affect HIV-1 coreceptor and ligand binding function. J. Biol. Chem., 274, 16228-16234.
35. Cairns, J.S. and D'Souza, M.P. (1998) Chemokines and HIV-1 second receptors: the therapeutic connection. Nature Med., 4, 563-569.
36. Cohen, J. (1997) Exploiting the HIV-chemokine nexus. Science, 278, 1580-1581.
37. Littman, D.R. (1998) Chemokine receptors: keys to AIDS pathogenesis? Cell, 93, 677-680.
38. McNicholl, J.M., Smith, D.K., Qari, S.H. and Hodge, T. (1997) Host genes and HIV: the role of the chemokine receptor gene CCR5 and its allele (Δ32 CCR5). Emerg. Infec. Dis., 3, 261-271.
39. O'Brien, S.J. (1998) A new approach to therapy. HIV Newsline, 4, 3-6.
40. He, J., Chen, Y., Farzan, M., Choe, H., Ohagen, A., Gartner, S., Bulsciglio, J., Yang, X., Hoffman, W., Newman, W., Mackay, C.R., Dosroski, J. and Gabuzda, D. (1997) CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature, 385, 645-649.
41. Wu, L., Gerard, N.P., Wyatt, R., Choe, H., Parolin, C., Ruffing, N., Borestti, A., Cardoso, A.A., Desjardin, E., Newman, W., Gerard, C. and Sodroski, J. (1996) CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR5. Nature, 384, 179-183.
42. Wu, L., LaRosa, G., Kassam, N., Gordon, C.J., Heath, H., Ruffing, N., Chen, H., Humblias, J., Samson, M., Parmentier, M., Moore, J.P. and Mackay, C.R. (1997) Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding. J. Exp. Med., 186, 1373-1381.
43. Bleul, C.C., Wu, L., Hoxie, J.A., Springer, T.A. and Mackay, C.R. (1997) The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl Acad. Sci USA, 94, 1925-1930.
44. Michael, N.L., Louie, L.G., Rohrbaugh, A.L., Schultz, K.A., Dayhoff, D.E., Wang, C.E. and Sheppard, H.W. (1997) The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression. Nature Med., 3, 1160-1162.
45. Samson, M., Labbe, O., Mollereau, C., Vassart, G. and Parmentier, M. (1996) Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry, 35, 3362-3367.
46. Combadiere, C., Ahuja, S.L., Tiffany, H.L. and Murphy, P.M. (1996) Cloning and functional expression of CC CCKR5, a human monocyte CC chemokine receptor selective for MIP-1α, MIP-1β, and RANTES. J. Leukocyte Biol., 60, 147-152.
47. Rapport, C.J., Gosling, J., Schweickart, V.L., Gray, P.W. and Charo, I.F. (1996). Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1β, and MIP-1α. J. Biol. Chem., 211, 17161-17166.
48. Moriuchi, H., Moriuchi, M. and Fauci, A.S. (1997) Cloning and analysis of the promoter region of CCR5, a coreceptor for HIV-1 entry. J. Immunol., 159, 5441-5449.
49. Guignard, F., Combadiere, C., Tiffany, H.L. and Murphy, P.M. (1998) Gene organization and promoter function for CC chemokine receptor 5 (CCR5). J. Immunol., 160, 985-992.
50. Mummidi, S., Ahuja, S.S., McDaniel, B.L. and Ahuja, S.K. (1997) The human CC chemokine receptor 5 (CCR5) gene. Multiple transcripts with 5′-end heterogeneity, dual promoter usage, and evidence for polymorphisms within the regulatory regions and noncoding exons. J Biol. Chem., 272, 30662-30671.
51. Lui, R., Zhao, X., Gurney, T.A. and Landau, N.R. (1998) Functional analysis of the proximal CCR5 promoter. AIDS Res., 14, 1509-1519.
52. Bream, J.H., Young, H.A., Rice, N., Martin, M.P., Smith, M.W., Carrington, M. and O'Brien, S.J. (1999) CCR5 promoter alleles and specific DNA binding factors. Science, 284, 223a.
53. Bonini, J.A., Martin, S.K., Dralyuk, F., Roe, M.W., Philipson, L.H. and Steiner, D.F. (1997) Cloning, expression, and chromosomal mapping of a novel human CC-chemokine receptor (CCR10) that displays high-affinity binding for MCP-1 and MCP-3. DNA Cell Biol., 16, 1249-1256.
54. Smith, M.W., Dean, M., Carrington, M., Winkler, C., Huttley, G., Lomb, D.A., Goedert, J., O'Brien, T., Jacobsen, L.P., Kaslow, R., Buchbinder, S., Vittinghoff, E., Vlahov, D., Hoots, K., Hilgartner, M.W., Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study and O'Brien, S.J. (1997) Contrasting genetic influence of CCK2 and CCR5 receptor gene variants on HIV-1 infection and disease progression. Science, 277, 959-965.
55. Kostrikis, L.G., Huang, Y., Moore, J.P., Wolinsky, S.M., Zhang, L., Guo, Y., Deutsch, L., Phair, J., Neumann, A.U. and Ho, D.D. (1998) A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nature Med., 4, 350-353.
56. Frade, J.M.R., Llorente, M., Mellado, M., Alcami, J., Guttierrez-Ramos, J.C., Zaballos, A., Real G. and Martinez, A.C. (1997) The amino-terminal domain of the CCR2 chemokine receptor acts as coreceptor for HIV-1 infection. J. Clin. Invest., 100, 497-502.
57. Lee, B., Doranz, B.J., Rana, S., Yi, Y., Mellado, M., Frade, J.M.R., Martinez, A.C., O'Brien, S.J., Dean, M., Collman, R.G. and Doms, R.W. (1998) Influence of the CCR2-V641 polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4. J. Virol., 72, 7450-7458.
58. Martin, M.P., Dean, M., Smith, M.W., Winkler, C.A., Gerrard, B., Michael, N., Margolick, J., Buchbinder, S., Goedert, J.J., O'Brien, T.R., Hilgartner, M.W., Hoots, K., Vlahov, D., O'Brien, S.J. and Carrington, M. (1998) Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science, 282, 1907-1911.
59. Mummidi, S., Ahuja, S.S., Gonzalez, E., Anderson, S.A., Santiago, E.N., Stephan, K.T., Craig, F.E., O'Connel, P., Tyron, V., Clark, R.A., Dolan, M.J. and Ahuja, S.J. (1998) Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nature Med., 4, 786-793.
60. McDermott, D.H., Zimmerman, P.A., Guignard, F., Kleeberger, C.A., Leitman, S.F. and Murphy, P.M. (1998) CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS). Lancet, 352, 866-870.